Silence Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Silence Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2145% to $5,479,000. Profit margin reached -594%. Total operating expenses were $34,192,000.
Profit Margin
| 2011 | 694K | -5.73M | -826.66% |
|---|---|---|---|
| 2012 | 163K | -26.28M | -16125.15% |
| 2013 | 117K | -9.00M | -7694.02% |
| 2014 | 15K | -11.08M | -73920% |
| 2015 | 0 | -6.64M | |
| 2016 | 770K | -8.44M | -1096.1% |
| 2017 | 16K | -1.61M | -10112.5% |
| 2018 | 0 | -18.41M | |
| 2019 | 244K | -19.58M | -8025.41% |
| 2020 | 5.47M | -32.54M | -594.03% |
SLN.L Income Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 5.47M | 244K | 0 | 16K | 770K | 0 | 15K | 117K | 163K | 694K |
Cost of revenue | 3.76M | 0 | 0 | 0 | 0 | 7.11M | 8.88M | 5.64M | 3.37M | 3.36M |
Gross profit | 1.71M | 244K | 0 | 16K | 770K | -7.11M | -8.86M | -5.53M | -3.21M | -2.66M |
Operating exp. | ||||||||||
Research and development | 20.20M | 13.33M | 9.74M | 7.94M | 8.71M | 7.11M | 8.88M | 5.64M | 3.37M | 3.36M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 34.19M | 22.97M | 20.57M | 14.40M | 12.67M | 9.76M | 12.14M | 9.18M | 5.72M | 6.01M |
Operating income | -36.02M | -22.83M | -20.52M | -3.76M | -10.36M | -9.42M | -11.98M | -9.00M | -5.55M | -5.32M |
Other income (expenses), net | -16K | -33K | 0 | -15K | 0 | 0 | 0 | 0 | -20.72M | 417K |
Income before tax | -36.04M | -22.87M | -20.52M | -3.77M | -10.36M | -9.42M | -11.98M | -9.00M | -26.28M | -5.73M |
Income tax expense | -3.49M | -3.28M | -2.11M | -2.15M | -1.92M | -2.78M | -892K | 0 | 0 | 0 |
Net income | -32.54M | -19.58M | -18.41M | -1.61M | -8.44M | -6.64M | -11.08M | -9.00M | -26.28M | -5.73M |
Earnings per share | ||||||||||
Basic EPS | -0.4 | -0.26 | -0.26 | -0.02 | -0.12 | -0.1 | -0.22 | -0.2 | -1.35 | -0.56 |
Diluted EPS | -0.4 | -0.26 | -0.26 | -0.02 | -0.12 | -0.1 | -0.22 | -0.2 | -1.35 | -0.56 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |